I maintain a buy rating on Varonis Systems, despite the recent share price drop due to short-term concerns over flat ARR growth and weaker margins. Read more here.

Commvault Systems (NASDAQ: CVLT) share price trended higher in 2023 and 2024, gaining more than 150% at the movement's peak, and can continue to trend higher in 2025 and beyond. The reason is ...

Commvault Systems CVLT share price trended higher in 2023 and 2024, gaining more than 150% at the movement's peak, and can continue to trend higher in 2025 and beyond.

Vdeal System share price lists with strong 52% premium at ₹170 on the NSE SME. The issue that opened for subscription on 27 August had closed on 29 August.

Eli Lilly says it plans to buy cancer-drug developer ImClone Systems for $70 a share, or about $6.5 billion, in an all-cash deal that is not subject to any financing conditions.

Technical traders have long searched for distinctive shapes in stock-price charts in order to predict returns. As artificial intelligence systems become better and better at recognizing visual ...

New York - Drugmaker Eli Lilly & Co. said Thursday it swung to a loss in the fourth quarter on charges from buying cancer-drug maker ImClone Systems Inc. Before charges for the acquisition, the ...

NEW YORK-- (BUSINESS WIRE)--ImClone Systems Incorporated (NASDAQ: IMCL) today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR), with respect ...

Eli Lilly and Company announced that its wholly-owned subsidiary, Alaska Acquisition Corporation, has commenced its tender offer for all outstanding shares of ImClone Systems Incorporated at a price ...

Bristol-Myers Squibb dug in its heels yesterday for a fight over the rights to ImClone Systems' most anticipated new cancer drug after the biotechnology company agreed to be acquired by Eli Lilly ...

Eli Lilly is to take over ImClone Systems after the companies ended speculation and agreed a definitive merger deal where drug giant Lilly will pay out $6.5 billion for the biopharmaceutical company – ...

INDIANAPOLIS -- Eli Lilly & Co.'s winning bid of more than $6 billion for cancer drug maker ImClone Systems means a billion-dollar payday for former rival bidder Bristol-Myers and vindication for ...